RST Introduces 'Demron-C' Line of Covid-19 Anti-Viral, Reusable
RST introduces Demron-C line of Covid-19 anti-viral reusable personal protective equipment (PPE) for Coronavirus first responders & healthcare workers
Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect
Sensors, Free Full-Text
Radiation Shield Technologies (RST) is the world leader in the research, design and production of personal protection systems for ionizing and nuclear
Demron C Suit
Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect
Sensors, Free Full-Text
Current trends and challenges in point-of-care urinalysis of biomarkers in trace amounts - ScienceDirect
RST Introduces 'Demron-C' Line of Covid-19 Anti-Viral, Reusable Personal Protective Equipment (PPE) for Coronavirus First Responders and Healthcare Workers
Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial, News Center
Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect
Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial, News Center